SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic slump today following the unexpected termination of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively read more to the news, sending the company's stock price plummeting by nearly fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts